IRIS
QUARTUCCIO, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.197
AS - Asia 8.250
EU - Europa 4.568
SA - Sud America 1.552
AF - Africa 202
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 28.788
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.974
SG - Singapore 3.916
CN - Cina 1.634
BR - Brasile 1.231
UA - Ucraina 1.062
HK - Hong Kong 850
VN - Vietnam 771
DE - Germania 672
IT - Italia 654
FI - Finlandia 414
RU - Federazione Russa 362
FR - Francia 354
GB - Regno Unito 249
IE - Irlanda 242
SE - Svezia 223
IN - India 201
TR - Turchia 187
AR - Argentina 118
CA - Canada 117
KR - Corea 112
BD - Bangladesh 102
AT - Austria 66
IQ - Iraq 66
JP - Giappone 65
EC - Ecuador 64
ZA - Sudafrica 64
ID - Indonesia 58
MX - Messico 55
NL - Olanda 53
PL - Polonia 44
CO - Colombia 41
PK - Pakistan 35
ES - Italia 32
EG - Egitto 29
UZ - Uzbekistan 29
CZ - Repubblica Ceca 28
IR - Iran 28
MA - Marocco 25
BE - Belgio 24
SA - Arabia Saudita 24
PY - Paraguay 23
CL - Cile 22
VE - Venezuela 22
PH - Filippine 21
TG - Togo 20
TN - Tunisia 18
AE - Emirati Arabi Uniti 17
LT - Lituania 16
AZ - Azerbaigian 12
MY - Malesia 12
UY - Uruguay 12
JO - Giordania 11
KZ - Kazakistan 11
OM - Oman 11
DO - Repubblica Dominicana 10
KE - Kenya 10
NP - Nepal 10
PE - Perù 10
PT - Portogallo 10
BO - Bolivia 9
CR - Costa Rica 9
DZ - Algeria 9
GR - Grecia 9
IL - Israele 9
JM - Giamaica 9
TT - Trinidad e Tobago 9
AL - Albania 7
LB - Libano 7
TH - Thailandia 7
TW - Taiwan 7
EE - Estonia 6
EU - Europa 6
KG - Kirghizistan 6
LK - Sri Lanka 6
RO - Romania 6
BY - Bielorussia 5
HR - Croazia 5
NZ - Nuova Zelanda 5
AU - Australia 4
CH - Svizzera 4
ET - Etiopia 4
PA - Panama 4
BN - Brunei Darussalam 3
GA - Gabon 3
HN - Honduras 3
KW - Kuwait 3
NO - Norvegia 3
PS - Palestinian Territory 3
RS - Serbia 3
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
BH - Bahrain 2
BW - Botswana 2
CI - Costa d'Avorio 2
CY - Cipro 2
DK - Danimarca 2
DM - Dominica 2
HU - Ungheria 2
KH - Cambogia 2
Totale 28.748
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.633
Singapore 1.578
Ann Arbor 1.122
Ashburn 1.120
Fairfield 1.061
Houston 970
Beijing 827
Hong Kong 823
Chandler 767
Jacksonville 680
Wilmington 519
Seattle 440
Dearborn 415
Boardman 355
San Jose 344
Cambridge 335
Lauterbourg 285
Ho Chi Minh City 239
Dublin 238
Princeton 229
Los Angeles 219
Udine 180
Dallas 155
Izmir 138
Hanoi 136
Hefei 129
Council Bluffs 125
São Paulo 122
Buffalo 113
Helsinki 107
Seoul 105
Redondo Beach 97
Des Moines 85
Dong Ket 80
Munich 79
San Diego 79
New York 75
Nuremberg 70
The Dalles 70
Ogden 60
Frankfurt am Main 55
Santa Clara 54
Orem 53
Norwalk 50
Milan 43
Ottawa 43
Tokyo 42
Redmond 41
London 40
Warsaw 40
Nanjing 38
Johannesburg 37
Rio de Janeiro 37
Mumbai 34
Trieste 33
Amsterdam 29
Brooklyn 29
Chennai 29
Montreal 29
Belo Horizonte 28
Stockholm 28
Tashkent 28
Da Nang 27
Haiphong 27
Atlanta 26
Belluno 26
Denver 26
Phoenix 26
Pittsburgh 26
San Mateo 26
Lappeenranta 25
Chicago 24
Düsseldorf 24
Guangzhou 24
Curitiba 23
Toronto 23
Guayaquil 22
Quito 22
Vienna 22
Brasília 21
Brno 21
Rome 21
Baghdad 20
Brussels 20
Hải Dương 20
Lomé 20
Turku 19
Manchester 17
Porto Alegre 17
Salvador 17
Shanghai 17
Biên Hòa 16
Kunming 16
Mexico City 16
Poplar 16
Auburn Hills 15
Boston 15
Falls Church 15
Lahore 15
San Francisco 15
Totale 17.832
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. 195
Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands 184
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 183
AB0695 Anti-prothrombin/phosphatidyl-serine complex autoantibodies in antiphospholipid syndrome: Preliminary data using a new ELISA method 179
Pain management in cryoglobulinaemic syndrome 179
Validation of the classification criteria for cryoglobulinaemic vasculitis. 178
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. 178
A randomized controlled trial of rituximab for treatment of severe cryoglobulinemic vasculitis. 177
A randomized, controlled, multicenter phase iii study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) Ann Rheum Dis 2010;69(Suppl3):93 174
Pachydermodactyly: The role of ultrasonography and dermoscopy for diagnosis 173
Acetaminophen-induced liver injury in a woman with febrile flare of systemic lupus erythematosus 170
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 167
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis 167
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 165
HCV-related liver and lymphoproliferative diseases: Association with polymorphisms of IL28B and TLR2 165
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. 165
Accuracy of Computer-Guided Flapless Implant Surgery in Fully Edentulous Arches and in Edentulous Arches With Fresh Extraction Sockets 164
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands 161
A B-cell activating factor receptor (BAFF-R) His159Tyr mutation in Sjögren's Syndrome related lymphoproliferation 160
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 160
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 159
Use of teriparatide in osteoporosis due to active rheumatic diseases 157
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study. 157
Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugs 157
Efficacy of intravenous cyclosporine in a case of cytophagic histiocytic panniculitis complicated by haemophagocytic syndrome after visceral leishmania infection 157
Prevalence of mixed cryoglobulinaemia syndrome and circulating cryoglobulins in a population-based survey: the Origgio study. 156
Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome 155
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. 154
Optimizing the dose of mycophenolate mofetil for the maintenance treatment of lupus nephritis by therapeutic drug monitoring. 152
A randomized, controlled, multicenter phase III study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) 151
Strontium ranelate and femural fracture healing during rheumatoid arthritis and osteoporosis 150
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis 150
Cost-effectiveness analysis of two Rituximab retreatment regimens for longstanding rheumatoid arthritis. 150
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 150
Patient-reported impact of spondyloarthritis on work disability and working life: The ATLANTIS survey 149
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides. 148
Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection 148
Development of the ClinESSDAI: A clinical score without biological domain. A tool for biological studies 147
Retrospective analysis of the usefulness of a protocol with high-dose methotrexate in polymyalgia rheumatica: Results of a single-center cohort of 100 patients 147
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 145
Role e of oral cyclophosphamide in the treatment of giant cell arteritis 143
Ciclosporina e tacrolimus nella miosite da corpi inclusi: efficacia clinica, sicurezza e risparmio nell'uso dei corticosteroidi 143
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution 143
Treatment of rheumatoid arthritis with rituximab: an update and possible indications. 142
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis 142
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 142
Apheresis treatment of cryoglobulinemic vasculitis: A multicentre cohort study of 159 patients 142
L. Quartuccio, M. Fabris, M. Maset, E. Pontarini, A. Zabotti, S. De Vita Bone marrow b-cell expansion in mixed cryoglobulinemia: association with nephritis and response to rituximab 141
Mycophenolic Acid AUC estimation in patients with lupus nephritis using an algorithm validated in an heart transplanted population 141
Dermoscopy of nail fold and elbow in the differential diagnosis of early psoriatic arthritis sine psoriasis and early rheumatoid arthritis 141
Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et al 140
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 140
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care 140
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 138
Classification of cryoglobulinemic vasculitis 136
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy. 136
B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis 136
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome. 135
Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis: reply 135
Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis 135
Myositis in primary sjögren's syndrome: data from a multicenter cohort 133
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. 133
Gastrointestinal Involvement in Systemic Vasculitis 133
Pregnancy and fetal outcome in patients with an established diagnosis of primary sjögren's syndrome 132
A randomized, controlled, multicenter phase III study of the efficacy and safety of Rituximab (RTX) monotherapy versus thebest available treatment in patients with mixedcryoglobulinemia syndrome, on behalf of the rituximab studygroup in cryoglobulinemic sindrome. 132
Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication. 130
Variations in lumbar and femural bmd after rituximab therapy in active rheumatoid arthritis 129
High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients 129
Efficacy and tolerability of repeated cycles of a once-weekly regimen of bortezomib in lupus. 128
A clinical-genetic score to identify surgically resected colorectal cancer patients benefiting from an adjuvant fluoropyrimidine-based therapy 128
Ultrasonographic detection of subclinical enthesitis and synovitis: a possible stratification of psoriatic patients without clinical musculoskeletal involvement 127
Efficacy of cyclosporin-A in the long-term management of thrombocytopenia associated with systemic lupus erythematosus 126
Fetal Outcome in Patients with an Established Diagnosis of Primary Sjögren’s Syndrome 125
Rituximab as possible first-line therapy for glomerulonephritis in HCV-related mixed cryoglobulinaemia 125
Clinical characterization and treatment outcome in a monocentric cohort of 45 patients with adult onset still's disease 125
Late relapses of hepatitis C virus-cured mixed cryoglobulinaemia associated with infection or cancer 125
Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjögren's syndrome 124
Rheumatoid factor positivity, a lower disability and a lower number of anti-tnf agents failed are associated with response to rituximab in rheumatoid arthritis 123
Pleuritis is a red flag for Adult-onset Still's disease which may require biologic therapies. 122
The-308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis 122
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients 122
Post-covid-19 arthritis and sacroiliitis: Natural history with longitudinal magnetic resonance imaging study in two cases and review of the literature 122
Gastrointestinal involvement in systemic vasculitis 122
Preliminary classification criteria for the cryoglobulinaemic vasculitis 121
Delayed Positivization of Cerebral Angiography in Reversible Cerebral Vasoconstriction Syndrome (RCVS) Presenting with Recurrent Subarachnoid Haemorrhage. 121
B-Lymphocyte Stimulator (BLyS) in mixed cryoglobulinemia sindrome: pathobiological and clinical implication 120
Safety of Rituximab in different rheumatic autoimmune diseases. A single centre experience in 85 cases. 2008 119
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia. 2007; 66 (Suppl. II): 121 119
The role of the il-6 promoter p in predicting rituximab efficacy in rheumatoid artolymorphism 118
efficacy of methotrexate in polymyalgia rheumatica 118
Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy. 118
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia 118
Articular and peripheral nervous system involvement are linked to the long-term outcome in primary Sjögren's syndrome: The relevance of single organ manifestations rather than a composite score as predictors 118
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients 118
Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab. 117
Association between bone marrow B cell clonal expansion and glomerulonephritis in type II mixed cryoglobulinaemia 117
Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study 117
prevalence of chlamydophila psittaci subclinical infection in italian patients with rheumatoid arthritis: etiopathological and therapeutic implications 115
Efficacy of Belimumab On Non-Malignant Parotid Swelling and Systemic Manifestations of Sjo¨gren’s Syndrome: Results of the Beliss Study. 114
Chlamydophila psittaci subclinical infection in chronic polyarthritis 114
Totale 14.193
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.970
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.970
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021585 0 0 0 0 0 0 0 0 0 84 325 176
2021/20221.678 62 173 89 138 44 48 91 109 25 235 369 295
2022/20232.035 248 95 38 221 208 544 35 147 296 38 77 88
2023/2024763 109 62 29 19 144 89 30 64 99 60 21 37
2024/20255.380 121 403 231 158 236 233 337 358 709 492 771 1.331
2025/20269.179 789 1.026 943 1.044 1.543 919 1.092 391 735 697 0 0
Totale 29.749